AACR Annual Meeting 2026
April 17–22, 2026 · San Diego · 2418 items
← Lung cancer: perioperative IO and KRAS NSCLC
taletrectinib
0 people · 0 posts
Records
| Drug / trial | Readout | Setting |
|---|---|---|
| taletrectinib | ROS1+ ORR 90%, DoR 49.7 mo | JCO concurrent with the meeting |
Other cases in this chapter
- adebrelimabPerioperative EFS HR 0.52
- CheckMate 77THigh pCR only in ctDNA clearers
- LCINS / Sherlock-Lung1,209 WGS: EGFR in never-smokers, KRAS in smokers
Floor
No posts under this topic yet.